This move is archived. Current quotes and coverage live on the stock page.
Follow NXG
NexgenRX Inc. experienced a significant boost in its stock price, reflecting positive investor sentiment.
NexgenRX Inc. (NXG.V) saw its stock surge by 20.00% yesterday, closing at CA$0.66. This impressive gain highlights growing confidence among investors in the company's financial performance and future prospects.
Investor takeaway: With a market cap of CA$46.9 million and a P/E ratio of 33, NexgenRX's recent performance may signal a potential upward trend worth monitoring for investors seeking growth opportunities.
Advertisement
NexgenRX Inc.
NXG.V
NXG.V
NexgenRX Inc.
WealthAwesomeMarket cap
$42.67M
P/E
20.0x
Div. yield
2.50%
Div. / share
$0.01
52W high
$0.74
52W low
$0.28
1W change
-1.64%
Beta
0.46
Analyst Price Targets
Based on analyst covering NXG · as of Sep 17, 2026
Wall Street analysts forecast NXG stock price to rise 608.3% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$4.25
+608.3% Upside
Current Price
C$0.60
Last close
Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on NXG's historical volatility
30-Day Vol
83.9%
Annualized
90-Day Vol
82.6%
Annualized
Trend (90d)
+50.0%
Annualized drift
90d Mean
C$0.72
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$0.64 | C$0.48 – C$0.85 |
| 60 trading days | C$0.68 | C$0.45 – C$1.02 |
| 90 trading days | C$0.72 | C$0.43 – C$1.18 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Advertisement
Bull case
The company has shown solid financial results, including a notable increase in revenues and net income in recent quarters. This strong performance could attract more investors and drive further growth.
Bear case
Despite the recent surge, the lack of significant news and the company's relatively small market cap could pose risks for investors, especially if future earnings do not meet expectations.
Recent Financial Performance
Advertisement
NexgenRX has reported strong financial results in its recent quarters, including a 20.8% increase in revenues and a 181% rise in net income for Q2 2026 compared to the previous year. Such performance can bolster investor confidence and contribute to stock price appreciation.
Market Sentiment and Future Outlook
The surge in NexgenRX's stock price may reflect positive market sentiment. Investors seem optimistic about the company's growth trajectory, especially given its recent financial achievements. However, potential investors should remain cautious and keep an eye on upcoming earnings reports to gauge sustainability.
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
